1. Home
  2. ENVA vs CELC Comparison

ENVA vs CELC Comparison

Compare ENVA & CELC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enova International Inc.

ENVA

Enova International Inc.

HOLD

Current Price

$157.42

Market Cap

3.9B

Sector

Finance

ML Signal

HOLD

Logo Celcuity Inc.

CELC

Celcuity Inc.

HOLD

Current Price

$111.27

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENVA
CELC
Founded
2011
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
3.1B
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
ENVA
CELC
Price
$157.42
$111.27
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
8
Target Price
$159.50
$100.13
AVG Volume (30 Days)
230.4K
629.3K
Earning Date
01-27-2026
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
73.62
N/A
EPS
10.82
N/A
Revenue
$1,414,115,000.00
N/A
Revenue This Year
$159.48
N/A
Revenue Next Year
$16.33
N/A
P/E Ratio
$14.56
N/A
Revenue Growth
20.78
N/A
52 Week Low
$79.41
$7.58
52 Week High
$168.68
$116.44

Technical Indicators

Market Signals
Indicator
ENVA
CELC
Relative Strength Index (RSI) 53.84 60.08
Support Level $151.28 $103.00
Resistance Level $164.00 $112.69
Average True Range (ATR) 4.63 6.44
MACD -1.31 0.07
Stochastic Oscillator 47.69 70.07

Price Performance

Historical Comparison
ENVA
CELC

About ENVA Enova International Inc.

Enova International Inc provides online financial services, including short-term consumer loans, line of credit accounts, and installment loans to customers mainly in the United States and and Brazil. Consumers apply for credit online, the company's technology platforms process the applications, and transactions are completed quickly and efficiently. Its customers are predominantly retail consumers and small businesses. Enova markets its financing products under the names CashNetUSA, NetCredit, OnDeck, Headway Capital, and Simplic. The company also operates a money transfer platform under the name Pangea. Geographically, the company generates a majority of its revenue from its business in the United States and the rest from other international countries.

About CELC Celcuity Inc.

Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.

Share on Social Networks: